Effect of concurrent of curcumin and caffeine on non-alcoholic fatty liver disease

Phase 2

Recruiting

• Conditions: on-alcoholic fatty liver disease.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20240715062438N1
• Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 26 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Willingness to participate in the study
people aged 18 to 60 years
no history of alcohol consumption
no other liver disorders, malignancies, cardiovascular, respiratory and kidney disorders
no history of weight loss or bariatric surgery in recent years
no drug use In the last 3 months
the absence of endocrine and metabolic disorders

Exclusion Criteria

Pregnancy or breastfeeding in women
The patient's unwillingness to continue participating in the study
Non-compliance with the supplement
Participating in a concurrent trial
Allergy to supplements

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biochemical markers. Timepoint: 8 weeks. Method of measurement: Colorimetric method.;Oxidative stress. Timepoint: 8 weeks. Method of measurement: Colorimetric method.;Inflammatory cytokine. Timepoint: 8 weeks. Method of measurement: ELISA.

Secondary Outcome Measures

Name	Time	Method
Creatinine level. Timepoint: 8 weeks. Method of measurement: colorimetric.